evaluation by stratification according to the diagnosis showed that the efficacy rates for the ks-r1 group and for the oral group were 87.5 % and 85.0 % against pharyngitis , 90.5 % and 90.0 % against tonsillitis and 84.2 % and 78.6 % against bronchitis , respectively .
C0031350
pharyngitis
C0040425
tonsillitis